Bristol-Myers Squibb Co. has agreed to upgrade plants it operates in Evansville and nearby Mount Vernon in order to cut output of a refrigerant that depletes ozone, the Justice Department and the U.S. Environmental Protection Agency said today.
The Princeton, N.J., company agreed to the improvements after discovering problems with hydrochlorofluorocarbons during an internal audit of 25 sites it operates. The audit was undertaken voluntarily after the EPA asked the company for assurance that the Evansville facility was in compliance with the Clean Air Act.
Bristol-Myers makes infant formula, nutritional supplements and pharmaceutical products at its Mead Johnson Nutritionals and Indiana Technical Operations locations.
A total of 17 units will be retired or retrofitted in Indiana, New Jersey and Puerto Rico.
The agreement was filed yesterday in U.S. District Court for the Southern District of Indiana in Evansville.